Jo Robays

Urbanization and tropical health — then and now

The Burden of Human African Trypanosomiasis

Major depressive disorder

Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Expression and extracellular release of a functional anti-trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the tsetse fly

Complexities of Assessing the Disease Burden Attributable to Leishmaniasis

The potential of predictive analytics to provide clinical decision support in depression treatment planning

Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels intoin vitrodiagnostics?

Leishmaniasis

Neglected tropical diseases

Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide

Diagnosing human African trypanosomiasis in Angola using a card agglutination test: observational study of active and passive case finding strategies

Human African Trypanosomiasis: Epidemiology and Control

Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers

WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders.

Human African trypanosomiasis

Panowamycins A and B, new antitrypanosomal isochromans produced by Streptomyces sp. K07-0010

The gut microbiota of insects – diversity in structure and function

Lipsosomal Amphotericin B for Treatment of Cutaneous Leishmaniasis

pROC: an open-source package for R and S+ to analyze and compare ROC curves

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused byLeishmania braziliensisin Peru and Bolivia

Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Novel Low-Cost Thermotherapy for Cutaneous Leishmaniasis in Peru

Control of Neglected Tropical Diseases

LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014

Interventions for American cutaneous and mucocutaneous leishmaniasis

The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta‐analysis of randomized‐controlled clinical trials

Health and Wealth among the Poor: India and South Africa Compared

Simple Telemedicine for Developing Regions: Camera Phones and Paper-Based Microfluidic Devices for Real-Time, Off-Site Diagnosis

Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

Molecular Dipstick Test for Diagnosis of Sleeping Sickness

Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects

The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo

Novel Markers for Treatment Outcome in Late‐StageTrypanosoma brucei gambienseTrypanosomiasis

Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for Sleeping Sickness Diagnosis and Staging

Eflornithine is a cost‐effective alternative to melarsoprol for the treatment of second‐stage human West African trypanosomiasis in Caxito, Angola

Clinical and Parasite Species Risk Factors for Pentavalent Antimonial Treatment Failure in Cutaneous Leishmaniasis in Peru

Efficience de différentes stratégies de détection de la Trypanosomiase Humaine Africaine àT. b. gambiense

Validité, coût et faisabilité de la mAECT et CTC comme tests de confirmation dans la détection de la Trypanosomiase Humaine Africaine

Human African trypanosomiasis amongst urban residents in Kinshasa: a case‐control study

Cost-effectiveness of Algorithms for Confirmation Test of Human African Trypanosomiasis

Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003

High Failure Rates of Melarsoprol for Sleeping Sickness, Democratic Republic of Congo